IPCA Laboratories Ltd. | Mutual Funds
Mutual Funds that own IPCA Laboratories Ltd.
HDFC Mid Cap Opportunities Fund
3,711,400
2.94%
0
1.31%
07/31/2018
DSP BlackRock Micro Cap Fund
2,499,638
1.98%
0
3.38%
02/28/2018
ICICI Prudential Tax Plan
2,304,735
1.82%
0
3.08%
08/31/2018
GS Funds - India Equity Portfolio
2,087,632
1.65%
0
0.88%
06/30/2018
DSP BlackRock Small & Mid Cap Fund
2,028,921
1.61%
0
2.71%
07/31/2018
L&T Emerging Businesses Fund
1,710,403
1.35%
244,484
2.43%
07/31/2018
Government Pension Fund - Global (The)
1,562,049
1.24%
-1,530
0%
12/31/2017
UTI - Equity Fund
1,177,216
0.93%
0
1.02%
08/31/2018
Franklin India Smaller Companies Fund
1,096,154
0.87%
-200,000
1.13%
07/31/2018
DSP BlackRock Tax Saver Fund
975,518
0.77%
0
1.59%
07/31/2018
| Address |
142-AB, Kandivli Industrial Estate
Mumbai Maharashtra 400067
India
|
|
Employees
|
- |
| Website |
http://www.ipcalabs.com |
| Updated |
09/14/2018 |
| Ipca Laboratories Ltd. engages in the manufacture, research, and development of pharmaceutical products. It offers active pharmaceuical ingredients such as Atenolol, Chloroquine Phosphate, Furosemide, Hydroxychloroquine Sulphate, Metoprolol Succinate, Metoprolol Tartrate, and Pyrantel Salts. The company was founded on October 19, 1949 and is headquartered in Mumbai, India. |
